Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
E-Cigarette Manufacturers Have 10 Months To Apply For Application To Keep From Being Banned: Court Ruling July 22, 2019 Irvin Jackson Add Your CommentsManufacturers of electronic cigarette have only 10 months to reapply for federal approval to sell their vape pens and other products, or sale of the devices will be banned in the United States, according to a federal judge.U.S. District Judge Paul W. Grimm issued a memorandum opinion and order (PDF) on July 12, which grants a motion by the American Academy of Pediatrics (AAP) that called for a firm deadline.The Academy won a lawsuit against the FDA in May 2019, tossing out an extension granted to e-cigarette manufacturers by the agency in 2017, which provided more time for manufacturers to seek federal approval for their products under the FDA’s authority to control tobacco regulations. The AAP filed a motion for summary judgment, and Judge Grimm determined that the deadline to reapply is ten months from his ruling.LEARN MORE ABOUTVAPE PEN AND E-CIG LAWSUITSSerious lung injuries, respiratory illnesses, and nicotine addiction have been linked to a wide range of vaping products, including e-cigarettes and THC vape pens. Lawsuits are being pursued against manufacturers for failing to warn users about these risks.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONLearn More AboutVAPE PEN AND E-CIG LAWSUITSSerious lung injuries, respiratory illnesses, and nicotine addiction have been linked to a wide range of vaping products, including e-cigarettes and THC vape pens. Lawsuits are being pursued against manufacturers for failing to warn users about these risks.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONโBalancing the need to address the existing public health crisis among todayโs youth, which both parties acknowledge, and the need to avoid creating an additional public health crisis if e-cigarette availability dropped so precipitously as to push users to combusted tobacco products, and considering both the FDAโs laudable efforts to guide the premarket approval process and the Industryโs lack of effort to obtain approval without an imminent deadline, I will impose a ten-month deadline for submissions and a one-year deadline for approval, as the FDA suggested,โ Judge Grimm ruled.FDA Acting Commissioner Norman Sharpless responded to the ruling in a July 15 press release, saying the FDA is ready to accelerate the review process and that it has become concerned over the brewing health crisis of teen vaping. In addition, he said the FDA will continue to take vigorous enforcement action to keep e-cigarettes away from children.Sharpless noted that the FDA issued nearly 4,000 warning letters and more than 665 fines against retailers for illegal sales of e-cigarettes and vaping products to minors from April 2018 to April 2019.Additional public education efforts will also be launched by the FDA later this month, including television spots and new posters for high schools.E-Cigarette Approval ProcessLast month, following Judge Grimmโs initial decision to toss the extension, the FDA announced final guidance on how e-cigarette manufacturers should seek official authorization to market Electronic Nicotine Delivery Systems (ENDS), which includes e-cigarettes, vapes, and all liquids used by them. All past, present and future e-cigarette manufacturers will be required to go through a premarket tobacco product application (PMTA) if they want to continue to sell products in the U.S.It is unclear how strict the FDA will be, with those on one side of the issue fearing the FDA will rubber-stamp the approvals, and others concerned that the agency will make the approval process a de facto ban.The final guidance issued by the FDA lists a series of recommendations for manufacturers to consider when submitting their application. This includes instructions on explaining how they intend to market their products in a way that discourages teen and underage use. The guidance also warns that manufacturers should provide details on how they intend to prevent lithium ion batteries used in e-cigarettes from exploding.Both teen use and battery explosions have been major focuses of the agency, particularly the issue of underage use. Last year, the agency announced a plan to remove many of the flavored e-cigarettes products from store shelves, which are believed to be behind the increasing teen use of the tobacco products.The policy was directed at all flavors used in e-cigarettes except tobacco, mint or menthol-flavored products, as the agency recognized these flavors are typically used by adults transitioning away from traditional cigarette smoking.E-cigarette use has quickly become the most popular form of tobacco use among teens, with rates jumping 78 percent from 2017 to 2018, according to the FDA. In 2011, when the FDA first said it would regulate e-cigarettes, only 1.5 percent of teens vaped, but now more than one-third of teens use e-cigarettes as they have become increasingly popular among all age ranges.The Centers for Disease Control and Prevention (CDC) found nearly 14% of middle school students, and 38% of high school students reported having used e-cigarettes. Among use in the last 30 days from when the survey was taken, five percent of middle schoolers and 16% of high school students reported having used vaping devices.In April 2019, the FDA warned that it had received at least 35 reports ofย seizures linked to electronic cigarettesย since 2010, and believes many more may have gone unreported. The agency is currently investigating the problem, which preliminary indications suggest occur more often in younger users.In addition to increased regulatory actions, a number of manufacturers face vaping addiction and injury lawsuits filed in courts nationwide. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Battery, Children, Electronic Cigarette, Explosion, Juul, Lithium Ion Batteries, VapingMore JUUL E-Cigarette Vape Lawsuit Stories More Than Half of U.S. Teens Who Vape Do So To Deal With Stress, Anxiety: Study November 18, 2024 On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024 Vaping Causes Same DNA Damage as Smoking, Study Finds April 12, 2024 0 Comments CompanyThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Bard PowerPort Fracture Lawsuit Set For Second Bellwether Trial in Aug. 2026 (Posted: yesterday)The second Bard PowerPort bellwether trial is now scheduled to begin in August after the plaintiff in a claim originally planned for trial next month died, and her family stopped pursuing litigation.MORE ABOUT: BARD POWERPORT LAWSUITJury Returns Defense Verdict in First Bard PowerPort Injury Lawsuit (05/11/2026)Jury Selection Underway in First Bard PowerPort Trial Over Infection Claims (04/16/2026)Judge Blocks Juries From Hearing About IVC Filter Problems in Bard PowerPort Trials (04/08/2026) Dupixent Cancer Lawsuit Claims Eczema Drug Caused Womanโs CTCL Diagnosis (Posted: yesterday)A Delaware woman has filed a Dupixent lawsuit, claiming manufacturers promoted the eczema drug as a breakthrough treatment while failing to warn that it may trigger or worsen CTCL, a rare form of non-Hodgkinโs lymphoma.MORE ABOUT: DUPIXENT LAWSUITLink Between Dupixent and Cancer Withheld From Doctors and Users, Lawsuit Alleges (05/11/2026)Lawsuit Indicates Dupixent Lymphoma Diagnosis Resulted in Multiple Rounds of Chemotherapy (05/01/2026)Judges Will Consider MDL for Dupixent Cancer Lawsuits Late Next Month (04/21/2026) Omnipod Recall Impacts Another 7 Million Defective Pods That May Cause DKA, Hospitalization (Posted: 2 days ago)Federal regulators have expanded an Omnipod recall after reports that internal tubing defects may cause insulin leaks and under-delivery, potentially triggering dangerous blood sugar spikes.MORE ABOUT: OMNIPOD RECALL LAWSUITRecalled Omnipod 5 Injuries Skyrocket, Prompting Removal of Insulin Pump Pods (04/30/2026)Insulet OmniPod 5 Recall Lawsuits May Be Filed Over Problems Resulting in Diabetic Ketoacidosis, Hospitalization and Death (03/24/2026)Omnipod 5 Insulin Pump Recall Follows Reports of Serious Injuries: FDA (03/20/2026)
On-Line Retailers Receive FDA Warning Letter Over Illegal Sale of Disposable E-Cigarettes May 7, 2024
Bard PowerPort Fracture Lawsuit Set For Second Bellwether Trial in Aug. 2026 (Posted: yesterday)The second Bard PowerPort bellwether trial is now scheduled to begin in August after the plaintiff in a claim originally planned for trial next month died, and her family stopped pursuing litigation.MORE ABOUT: BARD POWERPORT LAWSUITJury Returns Defense Verdict in First Bard PowerPort Injury Lawsuit (05/11/2026)Jury Selection Underway in First Bard PowerPort Trial Over Infection Claims (04/16/2026)Judge Blocks Juries From Hearing About IVC Filter Problems in Bard PowerPort Trials (04/08/2026)
Dupixent Cancer Lawsuit Claims Eczema Drug Caused Womanโs CTCL Diagnosis (Posted: yesterday)A Delaware woman has filed a Dupixent lawsuit, claiming manufacturers promoted the eczema drug as a breakthrough treatment while failing to warn that it may trigger or worsen CTCL, a rare form of non-Hodgkinโs lymphoma.MORE ABOUT: DUPIXENT LAWSUITLink Between Dupixent and Cancer Withheld From Doctors and Users, Lawsuit Alleges (05/11/2026)Lawsuit Indicates Dupixent Lymphoma Diagnosis Resulted in Multiple Rounds of Chemotherapy (05/01/2026)Judges Will Consider MDL for Dupixent Cancer Lawsuits Late Next Month (04/21/2026)
Omnipod Recall Impacts Another 7 Million Defective Pods That May Cause DKA, Hospitalization (Posted: 2 days ago)Federal regulators have expanded an Omnipod recall after reports that internal tubing defects may cause insulin leaks and under-delivery, potentially triggering dangerous blood sugar spikes.MORE ABOUT: OMNIPOD RECALL LAWSUITRecalled Omnipod 5 Injuries Skyrocket, Prompting Removal of Insulin Pump Pods (04/30/2026)Insulet OmniPod 5 Recall Lawsuits May Be Filed Over Problems Resulting in Diabetic Ketoacidosis, Hospitalization and Death (03/24/2026)Omnipod 5 Insulin Pump Recall Follows Reports of Serious Injuries: FDA (03/20/2026)